Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Finance Today.
Press releases published on April 1, 2025

Colliers Announces Voting Results
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX: CIGI; NASDAQ: CIGI) (“Colliers” or the “Company”) today announced that at its annual meeting of shareholders held virtually on April 1, 2025, the ten director nominees …

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below. The …

Petrus Resources Declares Monthly Dividend for April 2025
CALGARY, Alberta, April 01, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable April 30, 2025, to …

Element to Announce Q1 2025 Results and Host Conference Call on May 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX: EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, will hold its Q1 2025 results conference call and webcast for …

Lumine Group Completes the Purchase of Vidispine
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group”) today announced the completion of the purchase of the Vidispine brand and business assets (“Vidispine”) from Arvato Systems, a subsidiary of Bertelsmann SE …

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …

Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona
EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and …

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces …

Guggenheim Investments Announces April 2025 Closed-End Fund Distributions
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” …

Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company exchanged $11.0 million of its subordinated …

Safe & Green Holdings Reports Year-End 2024 Results
MIAMI, April 01, 2025 (GLOBE NEWSWIRE) -- Safe …

HCW Biologics Announces 1-for-40 Reverse Stock Split
MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …

The Education PlanⓇ: April is Financial Literacy Month
Santa Fe, NM, April 01, 2025 (GLOBE NEWSWIRE) -- April is Financial Literacy Month, the perfect time to learn about and plan for financial stability and success. Established more than two decades ago, Financial Literacy Month promotes financial wellness by …

Antelope Enterprise Announces One-for-40 Reverse Stock Split
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), the majority interest owner of Kylin Cloud, a livestreaming e-commerce business in China, …

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned …

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.077 per Share
CHICAGO, April 01, 2025 (GLOBE NEWSWIRE) -- XAI Octagon Floating Rate …

XAI Madison Equity Premium Income Fund Declares Monthly Distributions of $0.06 per Share Payable on May 1, June 2, and July 1, 2025
CHICAGO, April 01, 2025 (GLOBE NEWSWIRE) -- XAI Madison Equity Premium Income Fund (the “Fund”), has declared its regular monthly distribution of $0.06 per share on the Fund’s common shares (NYSE: MCN) payable on May 1, 2025, June 2, 2025, and July 1, 2025 …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …